These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 14597587)

  • 21. Relation of early improvement in coronary flow reserve to late recovery of left ventricular function after beta-blocker therapy in patients with idiopathic dilated cardiomyopathy.
    Sugioka K; Hozumi T; Takemoto Y; Ehara S; Ogawa K; Iwata S; Oe H; Matsumura Y; Otsuka R; Yoshiyama M; Yoshikawa J
    Am Heart J; 2007 Jun; 153(6):1080.e1-6. PubMed ID: 17540213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional improvement in heart failure patients treated with beta-blockers is associated with a decline of cytokine levels.
    Mayer B; Holmer SR; Hengstenberg C; Lieb W; Pfeifer M; Schunkert H
    Int J Cardiol; 2005 Aug; 103(2):182-6. PubMed ID: 16080978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of beta-blockade and atropine on ischemic responses in left ventricular regions subtending coronary stenosis during dobutamine stress echocardiography.
    Chen L; Ma L; de Prada VA; Chen M; Feng YJ; Waters D; Gillam L; Chen C
    J Am Coll Cardiol; 1996 Dec; 28(7):1866-76. PubMed ID: 8962578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Marked improvement in left ventricular ejection fraction during long-term beta-blockade in patients with chronic heart failure: clinical correlates and prognostic significance.
    Metra M; Nodari S; Parrinello G; Giubbini R; Manca C; Dei Cas L
    Am Heart J; 2003 Feb; 145(2):292-9. PubMed ID: 12595847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dose-response of chronic beta-blocker treatment in heart failure from either idiopathic dilated or ischemic cardiomyopathy. Bucindolol Investigators.
    Bristow MR; O'Connell JB; Gilbert EM; French WJ; Leatherman G; Kantrowitz NE; Orie J; Smucker ML; Marshall G; Kelly P
    Circulation; 1994 Apr; 89(4):1632-42. PubMed ID: 7908610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of improvement in left ventricular ejection fraction with carvedilol for congestive heart failure.
    O'Keefe JH; Magalski A; Stevens TL; Bresnahan DR; Alaswad K; Krueger SK; Bateman TM
    J Nucl Cardiol; 2000; 7(1):3-7. PubMed ID: 10698228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Left ventricular contractile reserve by stress echocardiography as a predictor of response to cardiac resynchronization therapy in heart failure: a systematic review and meta-analysis.
    Ciampi Q; Carpeggiani C; Michelassi C; Villari B; Picano E
    BMC Cardiovasc Disord; 2017 Aug; 17(1):223. PubMed ID: 28814264
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NT-proBNP response to dobutamine stress echocardiography predicts left ventricular contractile reserve in dilated cardiomyopathy.
    Parthenakis FI; Patrianakos AP; Haritakis CN; Zacharis EA; Nyktari EG; Vardas PE
    Eur J Heart Fail; 2008 May; 10(5):475-81. PubMed ID: 18396456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tissue Doppler systolic velocity change during dobutamine stress echocardiography predicts contractile reserve and exercise tolerance in patients with heart failure.
    Ciampi Q; Pratali L; Porta MD; Petruzziello B; Manganiello V; Villari B; Picano E; Sicari R
    Eur Heart J Cardiovasc Imaging; 2013 Feb; 14(2):102-9. PubMed ID: 22613501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of carvedilol on left ventricular regional wall motion in patients with heart failure caused by ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group.
    Doughty RN; Whalley GA; Gamble G; MacMahon S; Sharpe N
    J Card Fail; 2000 Mar; 6(1):11-8. PubMed ID: 10746814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adrenergic receptor polymorphisms and prevention of ventricular arrhythmias with bucindolol in patients with chronic heart failure.
    Aleong RG; Sauer WH; Robertson AD; Liggett SB; Bristow MR
    Circ Arrhythm Electrophysiol; 2013 Feb; 6(1):137-43. PubMed ID: 23275278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of carvedilol on oxidative stress and chronotropic response to exercise in patients with chronic heart failure.
    Castro P; Vukasovic JL; Chiong M; Díaz-Araya G; Alcaino H; Copaja M; Valenzuela R; Greig D; Pérez O; Corbalan R; Lavandero S
    Eur J Heart Fail; 2005 Oct; 7(6):1033-9. PubMed ID: 16227141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multidimensional contractile reserve predicts adverse outcome in patients with severe systolic heart failure: a 4-year follow-up study.
    Paraskevaidis IA; Ikonomidis I; Simitsis P; Parissis J; Stasinos V; Makavos G; Lekakis J
    Eur J Heart Fail; 2017 Jul; 19(7):846-861. PubMed ID: 28220640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of contractile reserve assessed by dobutamine-induced changes of Tei index in patients with idiopathic dilated cardiomyopathy.
    Stipac AV; Otasević P; Popović ZB; Cvorović V; Putniković B; Stanković I; Nesković AN
    Eur J Echocardiogr; 2010 Apr; 11(3):264-70. PubMed ID: 19995800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diminished contractile reserve in patients with left ventricular hypertrophy and increased end-systolic stress during Dobutamine stress echocardiography.
    Fontanet HL; Pérez JE; Dávila-Román VG
    Am J Cardiol; 1996 Nov; 78(9):1029-35. PubMed ID: 8916483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term functional and clinical follow-up of patients with heart failure with recovered left ventricular ejection fraction after β-blocker therapy.
    de Groote P; Fertin M; Duva Pentiah A; Goéminne C; Lamblin N; Bauters C
    Circ Heart Fail; 2014 May; 7(3):434-9. PubMed ID: 24563449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dobutamine stress 99mTc-tetrofosmin quantitative gated SPECT predicts improvement of cardiac function after carvedilol treatment in patients with dilated cardiomyopathy.
    Kasama S; Toyama T; Kumakura H; Takayama Y; Ichikawa S; Tange S; Suzuki T; Kurabayashi M
    J Nucl Med; 2004 Nov; 45(11):1878-84. PubMed ID: 15534058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Failure of benefit and early hazard of bucindolol for Class IV heart failure.
    Anderson JL; Krause-Steinrauf H; Goldman S; Clemson BS; Domanski MJ; Hager WD; Murray DR; Mann DL; Massie BM; McNamara DM; Oren R; Rogers WJ;
    J Card Fail; 2003 Aug; 9(4):266-77. PubMed ID: 13680547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myocardial systolic synchrony measured by Doppler tissue imaging as a role of predictor of left ventricular ejection fraction improvement in severe congestive heart failure.
    Cho GY; Park WJ; Han SW; Choi SH; Doo YC; Oh DJ; Lee Y
    J Am Soc Echocardiogr; 2004 Dec; 17(12):1245-50. PubMed ID: 15562262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-dose carvedilol improves left ventricular function and reduces cardiovascular hospitalization in Japanese patients with chronic heart failure: the Multicenter Carvedilol Heart Failure Dose Assessment (MUCHA) trial.
    Hori M; Sasayama S; Kitabatake A; Toyo-oka T; Handa S; Yokoyama M; Matsuzaki M; Takeshita A; Origasa H; Matsui K; Hosoda S;
    Am Heart J; 2004 Feb; 147(2):324-30. PubMed ID: 14760332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.